Our industrial partners will play a fundamental role in achieving our goal of developing effective treatments for PSC. We value working with industry and understand the needs and the pressures on our industrial partners.

UK-PSC has been established in full collaboration with industry and has within its structures the elements for a unique public private partnership to allow us to identify potential therapies, to develop and optimise them, to evaluate them in practice and critically, to implement them.

  • The UK PSC cohort of over 1850 patients is the largest and best characterised in the world, with an active database of patients identifying key clinical and phenotypic groups relevant for trial work.
  • Participants will be consented to be approached about joining clinical trials.

Companies interested in working with PSC are welcome to contact Bridget Bell, the study Project Manager (B.F.Bell@bham.ac.uk) for informal or confidential discussions about opportunities.